These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2106770)

  • 1. Measuring costs and financial benefits in randomized controlled trials.
    Bulpitt CJ; Fletcher AE
    Am Heart J; 1990 Mar; 119(3 Pt 2):766-70; discussion 770-1. PubMed ID: 2106770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic assessments in randomized controlled trials.
    Bulpitt CJ; Fletcher AE
    Med J Aust; 1990 Aug; 153(S1):S16-9. PubMed ID: 2116582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost effectiveness of auranofin: results of a randomized clinical trial.
    Thompson MS; Read JL; Hutchings HC; Paterson M; Harris ED
    J Rheumatol; 1988 Jan; 15(1):35-42. PubMed ID: 3127585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide for rheumatoid arthritis in Germany: II. The contribution of leflunomide to efficiency.
    Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
    Pharmacoeconomics; 2005; 23(4):395-420. PubMed ID: 15853438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany.
    Gissel C; Götz G; Repp H
    Z Rheumatol; 2016 Dec; 75(10):1006-1015. PubMed ID: 27080399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany].
    Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
    Z Rheumatol; 2004 Feb; 63(1):59-75. PubMed ID: 14991279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab: a pharmacoeconomic review of its use in rheumatoid arthritis.
    Lyseng-Williamson KA; Foster RH
    Pharmacoeconomics; 2004; 22(2):107-32. PubMed ID: 14731052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods of assessing the effect of drug therapy on quality of life.
    Ganz PA
    Drug Saf; 1990; 5(4):233-42. PubMed ID: 2198049
    [No Abstract]   [Full Text] [Related]  

  • 9. Economic evaluation of an intervention program with the aim to improve at-work productivity for workers with rheumatoid arthritis.
    Noben C; Vilsteren MV; Boot C; Steenbeek R; Schaardenburg DV; Anema JR; Evers S; Nijhuis F; Rijk A
    J Occup Health; 2017 May; 59(3):267-279. PubMed ID: 28381814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in patients receiving auranofin therapy: confirmation of efficacy using nontraditional health status measures.
    Morgan GJ
    Scand J Rheumatol Suppl; 1986; 63():29-35. PubMed ID: 3299681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic analysis of randomized, controlled trials.
    Lyman GH
    Curr Oncol Rep; 2001 Sep; 3(5):396-403. PubMed ID: 11489239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial.
    Bombardier C; Ware J; Russell IJ; Larson M; Chalmers A; Read JL
    Am J Med; 1986 Oct; 81(4):565-78. PubMed ID: 3532786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation.
    Lambert CM; Hurst NP; Forbes JF; Lochhead A; Macleod M; Nuki G
    BMJ; 1998 Mar; 316(7136):965-9. PubMed ID: 9550954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of TNF-Blocker Injection Spacing for Patients with Established Rheumatoid Arthritis in Remission: An Economic Evaluation from the Spacing of TNF-Blocker Injections in Rheumatoid Arthritis Trial.
    Vanier A; Mariette X; Tubach F; Fautrel B;
    Value Health; 2017 Apr; 20(4):577-585. PubMed ID: 28407999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Now that we know what's BeSt, what is good value for the money?
    Bansback N; Marra CA
    Arthritis Rheum; 2009 Mar; 61(3):289-90. PubMed ID: 19248126
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of Tofacitinib in the Treatment of Moderate to Severe Rheumatoid Arthritis in South Korea.
    Lee MY; Park SK; Park SY; Byun JH; Lee SM; Ko SK; Lee EK
    Clin Ther; 2015 Aug; 37(8):1662-76.e2. PubMed ID: 26243076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The initial validation of a Markov model for the economic evaluation of (new) treatments for rheumatoid arthritis.
    Welsing PM; Severens JL; Hartman M; van Gestel AM; van Riel PL; Laan RF
    Pharmacoeconomics; 2006; 24(10):1011-20. PubMed ID: 17002483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness and cost utility analysis of multidisciplinary care in patients with rheumatoid arthritis: a randomised comparison of clinical nurse specialist care, inpatient team care, and day patient team care.
    van den Hout WB; Tijhuis GJ; Hazes JM; Breedveld FC; Vliet Vlieland TP
    Ann Rheum Dis; 2003 Apr; 62(4):308-15. PubMed ID: 12634227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of a brief education, self-management and upper limb exercise training in people with rheumatoid arthritis (EXTRA) programme: a trial-based analysis.
    Manning VL; Kaambwa B; Ratcliffe J; Scott DL; Choy E; Hurley MV; Bearne LM
    Rheumatology (Oxford); 2015 Feb; 54(2):302-9. PubMed ID: 25173349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial.
    de Jong PH; Hazes JM; Buisman LR; Barendregt PJ; van Zeben D; van der Lubbe PA; Gerards AH; de Jager MH; de Sonnaville PB; Grillet BA; Luime JJ; Weel AE
    Rheumatology (Oxford); 2016 Dec; 55(12):2138-2147. PubMed ID: 27581208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.